When to Order Imaging for Soft Tissue Masses: ACR Appropriateness Decoded
A patient presents to your clinic with a new, palpable lump on their forearm. It’s firm, non-tender, and has been slowly growing. The differential diagnosis is broad, ranging from a benign lipoma to a malignant sarcoma. Choosing the right initial imaging study is critical for accurate diagnosis, avoiding unnecessary radiation, and guiding the next steps in management. An incorrect first choice can lead to diagnostic delays and further, more costly workups. This guide decodes the American College of Radiology (ACR) Appropriateness Criteria for soft tissue masses, providing clear, evidence-based recommendations to help you select the most effective imaging pathway for your patient.
What Does ACR Soft Tissue Masses Cover?
The ACR Appropriateness Criteria for Soft Tissue Masses focuses on the initial diagnostic imaging for patients with a palpable or incidentally discovered soft tissue mass. The guidelines are structured to address common clinical scenarios, such as whether the mass is superficial or deep, and to provide next steps when initial imaging is nondiagnostic. The primary goal is to characterize the mass, determine its extent, and assess its relationship to adjacent structures like bone, vessels, and nerves.
These criteria do not apply to all clinical situations. Specifically, they are not intended for the evaluation of masses arising from specific organs (e.g., breast, liver, kidney), primary bone tumors, or for post-treatment surveillance of a known malignancy. The recommendations assume the mass has not been previously biopsied and that the clinical question is focused on initial characterization.
What Imaging Should I Order for Soft Tissue Masses? Recommendations by Clinical Scenario
The optimal imaging strategy for a soft tissue mass depends on its clinical characteristics, particularly its location. The ACR provides distinct recommendations for superficial versus deep masses and for situations where initial imaging is inconclusive.
For a superficial soft tissue mass, initial imaging with ultrasound is a key first step. The ACR rates Ultrasound (US) area of interest and Radiography area of interest as Usually appropriate. Ultrasound provides excellent characterization of superficial structures, can readily distinguish cystic from solid components, and involves no ionizing radiation. Radiography is valuable for identifying calcifications within the mass or assessing for underlying bone involvement.
When evaluating a nonsuperficial (deep) soft tissue mass for initial imaging, the approach shifts slightly. Radiography area of interest remains Usually appropriate to evaluate for bone changes or mineralization. However, US area of interest is rated as May be appropriate, as its utility can be limited by the depth of the mass and overlying structures. For deep masses, CT with or without contrast may also be considered and is rated May be appropriate.
If a patient has a soft tissue mass with a nondiagnostic radiograph and noncontrast enhanced ultrasound, further characterization is necessary. In this scenario, MRI area of interest without and with IV contrast is rated Usually appropriate. MRI offers superior soft tissue contrast, which is essential for defining the extent of the mass, its internal characteristics, and its relationship to neurovascular bundles, making it the primary problem-solving modality.
In the less common scenario where a patient has a soft tissue mass with nondiagnostic initial imaging and MRI is contraindicated (e.g., due to an incompatible implanted device or severe claustrophobia), an alternative cross-sectional study is needed. Here, CT area of interest with IV contrast is rated Usually appropriate. While it provides less soft tissue detail than MRI, contrast-enhanced CT is the best alternative for assessing the mass’s size, vascularity, and involvement of adjacent structures.
ACR Imaging Recommendations Table
| Clinical Scenario | Top Procedure | ACR Rating | Adult RRL | Pediatric RRL |
|---|---|---|---|---|
| Superficial soft tissue mass. Initial imaging. | US area of interest; Radiography area of interest | Usually appropriate | O 0 mSv; Varies | O 0 mSv [ped]; Varies |
| Nonsuperficial (deep) soft tissue mass. Initial imaging. | Radiography area of interest | Usually appropriate | Varies | Varies |
| Soft tissue mass. Nondiagnostic radiograph and noncontrast enhanced ultrasound. Next imaging study. | MRI area of interest without and with IV contrast | Usually appropriate | O 0 mSv | O 0 mSv [ped] |
| Soft tissue mass. Nondiagnostic radiograph and noncontrast enhanced ultrasound. MRI contraindicated. Next imaging study. | CT area of interest with IV contrast | Usually appropriate | Varies | Varies |
Adult vs. Pediatric Soft Tissue Masses Imaging: Radiation Dose Tradeoffs
When evaluating soft tissue masses in children, minimizing exposure to ionizing radiation is a primary concern. The principle of As Low As Reasonably Achievable (ALARA) guides imaging choices, favoring modalities that do not use radiation whenever possible. For pediatric patients, ultrasound and MRI are strongly preferred for soft tissue evaluation because they are radiation-free. The ACR guidelines reflect this by providing specific pediatric radiation relative level (RRL) indicators, marked with a “[ped]” tag, to highlight these considerations.
Ultrasound is particularly well-suited for initial evaluation of superficial masses in children. For deeper masses or when further characterization is needed, MRI is the modality of choice. CT is generally avoided as a primary imaging tool for soft tissue masses in children unless MRI is contraindicated or unavailable. When CT is necessary, protocols should be optimized to use the lowest possible radiation dose while maintaining diagnostic quality. Communicating the risks and benefits of radiation with parents or guardians is an important part of the shared decision-making process.
Imaging Protocol Details for Soft Tissue Masses
Once you’ve decided on the right study, the specific imaging protocol is crucial for obtaining diagnostic-quality images. Protocol parameters, such as MRI sequences or CT contrast timing, can significantly impact the characterization of a soft tissue mass. Our protocol guides cover technique, contrast, and reading principles for many of the studies recommended above.
Tools to Help You Order the Right Study
Navigating imaging guidelines and protocols can be complex. GigHz offers several tools designed to support clinical decision-making and streamline the imaging workflow for physicians and trainees.
The Imaging Appropriateness Selector provides a searchable interface for the full library of ACR guidelines, allowing you to quickly find evidence-based recommendations for hundreds of clinical scenarios beyond soft tissue masses.
For detailed procedural information, the Imaging Protocol Library offers a collection of standardized, scannable protocols for a wide range of CT, MRI, and ultrasound examinations, helping ensure the right images are acquired on the first attempt.
To help in discussions with patients about radiation exposure, the Radiation Dose Calculator is a useful tool for estimating cumulative radiation dose from various imaging studies and explaining the associated risks in clear, understandable terms.
Why is ultrasound often the first test for a superficial mass?
Ultrasound is an ideal first-line imaging modality for superficial masses because it provides excellent spatial resolution of soft tissues without using ionizing radiation. It can quickly and accurately determine if a mass is cystic or solid, measure its size, assess its vascularity with Doppler imaging, and guide a biopsy if needed. Its accessibility, low cost, and safety profile make it the preferred initial test in this setting.
When should I order an MRI for a soft tissue mass?
An MRI is typically ordered for a soft tissue mass in several situations: when initial imaging with ultrasound or radiographs is nondiagnostic or indeterminate; for the evaluation of deep masses that are not well-visualized by ultrasound; or for pre-operative planning. MRI’s superior soft tissue contrast is unmatched for defining the full extent of a mass, its relationship to adjacent nerves and blood vessels, and for characterizing its internal composition, which helps narrow the differential diagnosis and guide surgical management.
Is biopsy recommended as an initial step?
No, the ACR guidelines rate image-guided biopsy as Usually not appropriate for the initial imaging workup of a soft tissue mass. The standard approach is to perform imaging first to characterize the lesion. Imaging helps determine if the mass is likely benign (e.g., a simple lipoma) and needs no further workup, or if it is indeterminate or suspicious for malignancy. If a biopsy is required, imaging findings are crucial for planning the safest and most effective biopsy approach to obtain a diagnostic sample without contaminating uninvolved tissue compartments.
What features on a radiograph are important for soft tissue masses?
While radiographs have limited utility for visualizing soft tissue directly, they are valuable for identifying key associated features. Clinicians should look for the presence and pattern of calcifications within the mass (e.g., phleboliths in a hemangioma), evidence of underlying bone involvement such as erosion or a periosteal reaction, the presence of fat density (suggesting a lipoma), or any radiopaque foreign bodies that could be the cause of the mass.
Why is intravenous contrast important for MRI and CT of soft tissue masses?
Intravenous contrast agents are critical for evaluating the vascularity of a soft tissue mass. The pattern and degree of enhancement provide important diagnostic clues that can help differentiate between benign and malignant lesions. Malignant tumors are often highly vascular and may show heterogeneous or peripheral enhancement. Contrast also improves the delineation of the mass from surrounding edema, muscle, and vascular structures, which is essential for accurate staging and surgical planning.
Frequently Asked Questions
Why is ultrasound often the first test for a superficial mass?
Ultrasound is an ideal first-line imaging modality for superficial masses because it provides excellent spatial resolution of soft tissues without using ionizing radiation. It can quickly and accurately determine if a mass is cystic or solid, measure its size, assess its vascularity with Doppler imaging, and guide a biopsy if needed. Its accessibility, low cost, and safety profile make it the preferred initial test in this setting.
When should I order an MRI for a soft tissue mass?
An MRI is typically ordered for a soft tissue mass in several situations: when initial imaging with ultrasound or radiographs is nondiagnostic or indeterminate; for the evaluation of deep masses that are not well-visualized by ultrasound; or for pre-operative planning. MRI’s superior soft tissue contrast is unmatched for defining the full extent of a mass, its relationship to adjacent nerves and blood vessels, and for characterizing its internal composition, which helps narrow the differential diagnosis and guide surgical management.
Is biopsy recommended as an initial step?
No, the ACR guidelines rate image-guided biopsy as Usually not appropriate for the initial imaging workup of a soft tissue mass. The standard approach is to perform imaging first to characterize the lesion. Imaging helps determine if the mass is likely benign (e.g., a simple lipoma) and needs no further workup, or if it is indeterminate or suspicious for malignancy. If a biopsy is required, imaging findings are crucial for planning the safest and most effective biopsy approach to obtain a diagnostic sample without contaminating uninvolved tissue compartments.
What features on a radiograph are important for soft tissue masses?
While radiographs have limited utility for visualizing soft tissue directly, they are valuable for identifying key associated features. Clinicians should look for the presence and pattern of calcifications within the mass (e.g., phleboliths in a hemangioma), evidence of underlying bone involvement such as erosion or a periosteal reaction, the presence of fat density (suggesting a lipoma), or any radiopaque foreign bodies that could be the cause of the mass.
Why is intravenous contrast important for MRI and CT of soft tissue masses?
Intravenous contrast agents are critical for evaluating the vascularity of a soft tissue mass. The pattern and degree of enhancement provide important diagnostic clues that can help differentiate between benign and malignant lesions. Malignant tumors are often highly vascular and may show heterogeneous or peripheral enhancement. Contrast also improves the delineation of the mass from surrounding edema, muscle, and vascular structures, which is essential for accurate staging and surgical planning.
Reviewed by Pouyan Golshani, MD, Interventional Radiologist — May 26, 2026
